Wandercraft is a pioneering French robotics company focused on restoring mobility and augmenting human capability. Founded in 2012, the company is a global leader in the design and creation of advanced autonomous exoskeletons. Their technology, which features sophisticated dynamic balance algorithms, allows individuals with mobility impairments to stand up and walk again, completely hands-free.

After establishing themselves in the medical field with their clinical and personal exoskeletons, Wandercraft is now expanding its vision to address labor shortages and reduce the physical burden on workers in demanding industries. Leveraging their deep expertise in dynamic robotics, they have developed CALVIN-40, a bipedal humanoid robot designed to support workers by handling physically demanding tasks.

AI Used

Wandercraft's technology is built on a proprietary AI platform focused on dynamic balancing and motion control. This complex AI processes data from numerous sensors to mimic natural human gait and maintain stability, allowing their exoskeletons and robots to walk and react to the environment autonomously without the need for crutches. For their humanoid robot, CALVIN-40, this AI is adapted to handle lifting operations and object manipulation safely and reliably in industrial settings.

Robots & Products

• ATALANTE X: A self-balancing exoskeleton designed for clinical and rehabilitation environments. It enables patients with severe mobility impairments to stand, walk, and perform various exercises as part of their therapy, all while being hands-free.
• EVE: A personal exoskeleton designed for individuals to use at home and in their community. The goal of EVE is to provide a new level of daily independence and mobility for wheelchair users.
• CALVIN-40: Wandercraft's new bipedal humanoid robot. Moving beyond medical applications, CALVIN-40 is designed for industrial and logistics work. It leverages the company's balancing technology to provide "humanoid strength" for lifting operations, supporting human workers and caregivers.

Funding to Date

Wandercraft has raised significant capital, including a $45 million Series C round in 2021. Total funding is in the range of $80-90 million USD.

Why Choose Wandercraft

• World-Class Balancing Technology: Their core AI for dynamic, self-balancing walking is a key differentiator that removes the need for crutches, unlike many other exoskeletons.
• Proven Medical Impact: Their exoskeletons are used in leading rehabilitation centers and have a direct, life-changing impact on patients.
• Expansion into Industrial Humanoids: They are one of the few companies successfully translating deep expertise from medical exoskeletons into the burgeoning industrial humanoid market to address labor shortages.
• Focus on Autonomy: Both their exoskeletons and humanoid robots are designed for a high degree of autonomous operation.
  Strong Investor Confidence: Backed by major healthcare and technology investors who are confident in their vision and technology.

Funding

Raised approximately $80-90M total. Notable rounds include a $45M Series C in 2021 led by Quadrant Management, with participation from Bpifrance, MACSF, and others.